Ryxel

Market Recaps: Saturday, February 14, 2026

Macro & Geopolitical

  • January CPI rose 2.4% YoY vs 2.5% expected (both headline and core), lowest since May 2025, below expectations triggering broad market rally and increasing Fed rate cut odds, potentially bringing cuts forward from June to March/April
  • Trump administration planning steel and aluminum tariff roll-back focusing on derivative products rather than core commodities; STLD -3.32%, NUE -2.22%, AA -4%, CENX -6% as reduced trade barriers threaten domestic producer protection
  • U.S. military preparing for potentially weeks-long Iran operations per Reuters, energy sector elevated on geopolitical risk

Healthcare & Biotechnology

  • Disc Medicine Inc. (IRON): FDA issued Complete Response Letter for bitopertin EPP treatment, requires Phase 3 APOLLO results (expected Q4 2026) before approval, delaying potential approval until mid-2027, stock plunging -31%
  • Bio-Rad Laboratories Inc. (BIO): Q4 adjusted EPS $2.51 vs $2.74 consensus; revenue $693.2M vs $700.9M estimate; 2026 guidance of only 0.5-1.5% revenue growth with Q1 expected down low single digits, stock down ~11% to $260
  • Ultragenyx Pharmaceutical Inc. (RARE): Announced 10% workforce reduction (~130 employees) and ~$50M restructuring charges following failed Phase 3 trials for setrusumab and FDA delays for UX111 gene therapy, stock down 9.4% to $21.30
  • Citius Oncology Inc. (CTOR): First commercial revenue $3.9M from LYMPHIR launch in December 2025, marking transition to commercial-stage company; net loss improved to $5.5M from $6.7M prior year, stock up +4.4% on commercialization progress

Industrials & Manufacturing

  • Badger Meter Inc. (BMI): Expanded share repurchase authorization by $75M to $150M total through Nov 2028 with $119.7M remaining; declared quarterly dividend $0.40/share payable March 13; 21.5% ROE with $4.62B market cap
  • Cohu Inc. (COHU): Q4 adjusted loss of -$0.15 vs $0.06 expected (missed by $0.21); revenue $122.2M slightly beat $122.1M consensus; stock plunging -12.16% on surprise EPS miss
  • Sensient Technologies Corporation (SXT): Q4 adjusted EPS $0.72 vs $0.78 estimate; revenue $393.4M vs $395.7M consensus; operating income declined 9.1% YoY to $38.2M, stock gapping down 6.3% to $91.74

Financials & Real Estate

  • Chemed Corporation (CHE): Board authorized additional $300M for stock repurchase (~4.5% of $6.7B market cap) alongside $0.60 quarterly dividend, marking 219th consecutive quarterly dividend payment
  • Marcus & Millichap Inc. (MMI): Q4 EPS $0.34 vs $0.005 estimate; revenue $244M vs $194M est (25.9% beat); net income $13.3M vs $8.5M YoY (+57%); $42M remaining in buyback authorization, $20.4M dividends paid in 2025
  • CBL & Associates Properties, Inc. (CBL): FFO adjusted EPS $2.25 beat estimates by +1507%; Q4 same-center NOI growth 3.3%; maintained $1.80 annual dividend (~5% yield) with active $25M buyback

Consumer & Transportation

  • Norwegian Cruise Line Holdings Ltd. (NCLH): Board appointed John W. Chidsey (former Subway/Burger King CEO) to replace Harry Sommer who stepped down after 30+ years; stock down 6% to $21.86 on leadership uncertainty for $10.4B market cap operator
  • Alliance Entertainment Holding Corp. (AENT): Missed Q2 EPS by 42% ($0.18 vs $0.31 est) and revenue by 11% ($368.7M vs $414.8M est), triggering 13.8% stock decline; gross margin expanded 210 bps to 12.8% but top-line shortfall outweighed margin gains
  • Farmer Brothers Company (FARM): Q2 EPS -$0.22 vs -$0.085 est (-158.8% miss); gross margin collapsed 680 bps to 36.3% from 43.1% YoY; net loss widened to $4.9M vs $200K profit year-ago

Utilities

  • Eversource Energy (ES): Unveiled $26.5B capital investment plan targeting 57% EPS growth through 2030; Q4 EPS beat at $1.12 vs $1.10 est; dividend raised to $3.01/share; stock surging 4.3% on strategic outlook

WATCHLIST

Disc Medicine (IRON) - FDA CRL delays approval until 2027 Bio-Rad (BIO) - Weak 2026 guidance, down 11% Ultragenyx (RARE) - Restructuring after Phase 3 failures Norwegian Cruise (NCLH) - CEO transition uncertainty Cohu (COHU) - Surprise adjusted loss Sensient (SXT) - Q4 miss, down 6.3% Steel Dynamics (STLD) - Tariff rollback impacts Alcoa (AA) - Tariff rollback pressure Eversource (ES) - 57% EPS growth plan through 2030